Senior team members at RM Global have advised on and completed the following transactions and assignments:
Acquisition of EPD Biotherapeutics
Advised Genexine on the foregoing transaction
Divestiture and Spinoff of TETEC-AESCULAP Global Orthobiologics Business to Octane Medical
Advised B. Braun on the foregoing transaction
Strategic Collaboration
Advised Sensome on the foregoing transaction
Asset Acquisition
Advised GC Biopharma on the foregoing transaction
Global Licensing Agreement
Advised Chong Kun Dang Pharm on the foregoing transaction
Shanghai Easy-Flow Medical Technology Co., Ltd.
Advised Control Medical Technology on the foregoing transaction
Acquisition
Advised Genome & Company on the foregoing transaction
Global Licensing Agreement
Advised Brickell Biotech on the foregoing transaction
Series C Financing
Series A Financing
Advised R3 Vascular on the foregoing transaction
Equity investment in Scioto Biosciences’ Series B and Strategic Collaboration with Scioto Biosciences
Advised Genome & Company on the foregoing transaction
Series B Financing
Advised Adicet Bio on the foregoing transaction